McConnell Jamie L, Wadzinski Brian E
Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232-6600, USA.
Mol Pharmacol. 2009 Jun;75(6):1249-61. doi: 10.1124/mol.108.053140. Epub 2009 Mar 19.
With the recent clinical success of drugs targeting protein kinase activity, drug discovery efforts are focusing on the role of reversible protein phosphorylation in disease states. The activity of protein phosphatases, enzymes that oppose protein kinases, can also be manipulated to alter cellular signaling for therapeutic benefits. In this review, we present protein serine/threonine phosphatases as viable therapeutic targets, discussing past successes, current challenges, and future strategies for modulating phosphatase activity.
随着近期靶向蛋白激酶活性药物在临床上取得成功,药物研发工作正聚焦于可逆性蛋白磷酸化在疾病状态中的作用。蛋白磷酸酶是与蛋白激酶作用相反的酶,其活性也可被调控,以改变细胞信号传导从而获得治疗益处。在本综述中,我们将蛋白丝氨酸/苏氨酸磷酸酶作为可行的治疗靶点进行阐述,讨论过去的成功案例、当前面临的挑战以及调节磷酸酶活性的未来策略。